metronidazole

(redirected from acea)
Also found in: Dictionary, Thesaurus, Acronyms.

metronidazole

 [mĕ″tro-nid´ah-zōl]
an antibacterial and antiprotozoal agent effective against obligate anaerobes; used as the base, administered orally and intravaginally in Trichomonas vaginalis infection in females and orally in T. vaginalis infection in males and in intestinal amebiasis. It is used orally or intravenously in extraintestinal amebiasis and infection by obligate anaerobic bacteria and intravenously for the prophylaxis of colonic perioperative infection. It is also used topically in the treatment of rosacea. The hydrochloride salt is administered intravenously for the same indications for which the base is used intravenously.

metronidazole

/met·ro·ni·da·zole/ (-ni´dah-zōl) an antiprotozoal and antibacterial effective against obligate anaerobes; used as the base or the hydrochloride salt. It is also used as a topical treatment for rosacea.

metronidazole

(mĕt′rə-nī′də-zōl′)
n.
A synthetic antimicrobial drug, C6H9N3O3, used to treat vaginal trichomoniasis, anaerobic bacterial infections, and intestinal amebiasis.

metronidazole

[met′rənī′dəzōl]
an antimicrobial with activity against anaerobic bacteria and protozoa.
indications It is prescribed in the treatment of a variety of infections, including amebiasis, trichomoniasis, anaerobic infections, antibiotic-induced infections, pseudomembranous colitis, and bacterial vaginosis.
contraindications First trimester of pregnancy, blood dyscrasias, organic disease, central nervous system disorders, or known hypersensitivity to this drug prohibits its use. It is contraindicated in nursing mothers.
adverse effects Among the more serious adverse effects are severe GI distress, dizziness, neutropenia, and neurological disturbances. A metallic taste in the mouth is commonly noted.

metronidazole

Noritate® Dermatology An antibiotic used for managing dermatitides and erythema of rosacea. See Rosacea Infectious disease An antibiotic used to treat bacterial, fungal, and parasitic infections; it is the most effective agent for H pylori infections.

metronidazole

An antibiotic drug effective against Trichomonas vaginalis and Entamoeba histolytica as well as many other organisms. It is especially useful in the treatment of amoebic dysentery and amoebic liver abscesses as well as ANAEROBIC infections. The drug is on the WHO official list. Brand names are Acea Gel, Elyzol, Flagyl, Metrosa and Zidoval. The drug is also formulated with the antifungal drug nystatin under the brand name Flagyl Compak and, for external use only, under the brand names Anabact, Metrogel, Metrotop and Rozex.

Metronidazole

An anti-infective agent regarded as the best available drug for treating trichomoniasis. It is sold under the trade names Flagyl and MetroGel.
Mentioned in: Trichomoniasis

metronidazole

; Flagyl antibacterial agent effective against anaerobic infections; adult dose = 500mg every 8 hours

metronidazole

(met´rənī´dəzōl´),
n a generic synthetic antibacterial compound available for both oral and intravenous use. It is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. In dentistry, it is used in the treatment of HIV, periodontal disease, and aggressive periodontitis.
metronidazole HCl,
n brand name: Flagyl, Metro IV, Protostat;
drug class: trichomonacide, amebicide, antiinfective;
action: direct-acting amebicide/trichomonacide binds, degrades DNA in organisms;
uses: intestinal amebiasis, amebic abscess, trichomoniasis, refractory trichomoniasis, bacterial anaerobic infections.

metronidazole

an antimicrobial compound effective against protozoa and anaerobic bacteria. Commonly used to treat trichomoniasis, amebiasis, giardiasis and balantidiasis.
References in periodicals archive ?
Oil motor synthetic sae 5w30 acea c3, c4, renault rn0720
In addition, demand for new cars is weakening, with customers increasingly reluctant to make large purchases or unable to find lenders willing to finance them, ACEA said.
The ACEA is also asking the EU to introduce incentives for car owners to scrap vehicles over eight years old in a bid to speed up rates of fleet renewal.
A total of 1,334,081 cars were registered in Europe last month, ACEA said, noting there was one fewer shopping days than a year earlier.
ACEA secretary Ivan Hodac, says: "CO2 related taxation of cars and of alternative fuels are an important tool in shaping consumer demand towards fuel-efficient cars.
Cars have become heavier and larger within their own different model segments, due to regulations on safety and air quality, and due to consumer preferences," says an ACEA report.
The ACEA report revealed a striking pattern in the registration statistics.
We are very excited about working with Ed2Go," says ACEA Executive Director Lora Jorgensen.
According to WRI, the ACEA agreement establishes industry-wide targets for average emissions from vehicles to reach 140 grams of CO2 per kilometer by 2008, with the possibility of extending the agreement to 120 grams of CO2 per kilometer by 2012.
He went on: ``These latest ACEA figures confirm just how well the market performed in contrast to the rest of Europe.
Under a voluntary agreement with the European Commission, the EU's executive branch, the ACEA is committed to achieving a target of average CO2 emissions of 140 grams-per-kilometer for new cars sold in the EU by 2008 -- a reduction of some 25% from the 1995 level, he said.
Other members of the ACEA - Ford, BMW, Renault and DaimlerChrysler - also have interests in teams.